Dow Jones Industrial Average Futures Rise On Monster Jobs Beat

Dow Jones Industrial Average (DJIA) futures are trading well above fair value this morning, as U.S. stocks eye a strong finish to the week. In focus this morning is a monster nonfarm payrolls report for June, which blew past expectations with 287,000 jobs added last month, compared to just 175,000 expected. Traders are also keeping a close eye on recovering crude futures, after yesterday's steep sell-off in oil prices crushed the Dow. At last check, crude oil futures for August were up 0.6% at $45.41 per barrel. 

Continue reading for more on today's market, including: ​

• The upbeat news that had Costco Wholesale Corporation (NASDAQ:COST) options in high demand. 
• The Chinese social media stock hitting all-time highs.
• What had these 2 healthcare stocks shooting higher?
• Plus... Sinking bond yields in Japan, the rallying cybersecurity stock, and a biotech that's dropped 25% pre-market. 

Futures on the Dow Jones Industrial Average (DJIA) are 110 points above fair value. 

5 Things You Need to Know Today
 

1. Japan's 10-year government bond yield hit another record low, with traders seeking "safety" ahead of today's U.S. jobs data.
2. The Chicago Board Options Exchange (CBOE) saw 723,234 call contracts traded on Thursday, compared to 435,767 put contracts. The resultant single-session equity put/call ratio fell to 0.60 , while the 21-day moving average stayed at 0.70.
3. For the second month in a row, retailer Gap Inc (NYSE:GPS) posted better-than-expected same-store sales figures. This time around the company announced a 2% increase in the figure, against an expected 3% drop. The shares are now eyeing a 4% jump when the market opens.
4. Cybersecurity stock Barracuda Networks Inc (NYSE:CUDA) has struggled in 2016, giving back 17% to sit at $15.51. Today, though, CUDA is ready to take off, after the company reported fiscal third-quarter earnings and revenue that topped analyst estimates. Ahead of the open, the shares are up 15%, and poised to defeat their 200-day moving average. 
5. Juno Therapeutics Inc's (NASDAQ:JUNO) closely watched experimental cancer drug trial has taken a turn for the worse. Specifically, the trial has been put on hold by the Food and Drug Administration (FDA), following the deaths of three patients. JUNO is inevitably collapsing pre-market,set to lose one-fourth of its value so far. 

Earnings and Economic Data

There are no other notable economic or earnings reports today. To see what's coming up on next week's schedule, click here. 

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check